Super Bowl excitement creates supply chain disruptions
UC associate dean encourages people to shop early
As businesses and individuals seek items such as chicken wings and Bengals apparel for Super Bowl gatherings, high demand is forcing some to adapt, WLWT reported.
Supply chain disruptions that have occurred throughout the COVID-19 pandemic have improved, said Chuck Sox, the associate dean of impact and partnerships for the University of Cincinnati Carl H. Lindner College of Business. However, high demand is leading to shortages of some items in the days leading up to the Super Bowl.
“It's concentrated in Cincinnati, in particular, this year, for obvious reasons,” Sox said. “Your local store might run out of your favorite brand of beer or might run out of chicken wings. So, you know, it's just important for us to get out early and shop around, see what we can find.”
Featured image: UC supply chain expert Chuck Sox. Screenshot courtesy of WLWT video.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Withrow Pathway to Lindner program challenges, motivates students
December 3, 2024
Three graduates of Cincinnati Public Schools’ Withrow University High School of Business credit the partnership between the school and the Carl H. Lindner College of Business for their enrollment in the college.
B-O-L-O-G-N-A: The staying power of Oscar Mayer’s jingle
December 3, 2024
Few commercials have the staying power of the Oscar Mayer bologna jingle, which still has a place in American culture 50 years after its debut. James Kellaris, a professor of marketing at the University of Cincinnati, explained to NPR’s All Things Considered why the advertisement was so successful.
Cancer Center study if vaccines can prevent lung cancer...
December 3, 2024
WLWT highlighted a University of Cincinnati Cancer Center clinical trial exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.